Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Non-cash Items (2023 - 2025)

Standard Biotools (LAB) reported Non-cash Items of $476000.0 for Q4 2025, up 17209.09% year-over-year from N/an in Q4 2024, and up 17209.09% on a QoQ basis from $2750.0 in Q4 2024.

Standard Biotools (LAB) has 3 years of Non-cash Items data on file, last reported at $476000.0 in Q4 2025.

  • Quarterly Non-cash Items rose 17209.09% year-over-year to $476000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $476000.0 (up 17209.09% YoY) and the FY2025 annual result came in at $476000.0, up 17209.09% from the prior year.
  • Non-cash Items advanced to $476000.0 in Q4 2025 per LAB's latest filing, from $2750.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $1.8 million in Q3 2023 and bottomed at $9.0 in Q2 2024.
  • The 3-year median for Non-cash Items is $2965.0 (2024), against an average of $385845.7.
  • The widest annual swing landed in 2024, when Non-cash Items slumped 99.99%; it then surged 17209.09% in 2025.
  • Tracing LAB's Non-cash Items over 3 years: stood at $439000.0 in 2023, then plunged by 99.37% to $2750.0 in 2024, then surged by 17209.09% to $476000.0 in 2025.
  • Per Business Quant, the three latest LAB Non-cash Items figures stand at $476000.0 (Q4 2025), $2750.0 (Q4 2024), and $196.0 (Q3 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Standard Biotools 448.37 Mn -6.80 Mn 11.31 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 476,000.00
Dec 31, 2025 476,000.00
Dec 31, 2024 2,750.00
Dec 31, 2024 2,750.00
Sep 30, 2024 196.00
Sep 30, 2024 196.00
Jun 30, 2024 9.00
Jun 30, 2024 9.00
Mar 31, 2024 2,965.00
Mar 31, 2024 2,965.00
Dec 31, 2023 439,000.00
Dec 31, 2023 439,000.00
Sep 30, 2023 1.78 Mn
Sep 30, 2023 1.78 Mn